Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. (IONQ) reported an insider stock sale by one of its officers, who serves as Chief Revenue Officer. On 11/20/2025, the reporting person sold 100,000 shares of IonQ common stock in an open market transaction at a weighted average price of $46.8906 per share. After this transaction, the officer beneficially owned 432,616 shares, held directly.
The filing notes that the trades were carried out under a pre-arranged Rule 10b5-1 trading plan that was adopted on March 14, 2025 and amended on August 21, 2025. The shares were sold in multiple trades at prices ranging from $43.59 to $49.41, and the reporting person has agreed to provide detailed price breakdowns upon request.
IonQ, Inc. reported that Chief Revenue Officer Rima Alameddine will leave the company, with her last day as an employee on November 24, 2025. Under IonQ’s Amended and Restated Executive Severance Plan and her PSU award agreement, she will receive cash severance equal to nine months of base salary, 100% of her 2025 target bonus, and a pro-rated portion of her 2025 bonus paid over nine months.
The company will pay COBRA health premiums for up to nine months after her coverage ends on November 30, 2025, and all unvested restricted stock units and options will fully vest, with PSUs vesting at target on a pro-rated basis. Ms. Alameddine will serve as a non-employee advisor from November 24 through December 31, 2025 at her current base salary. IonQ also announced, via a press release filed as an exhibit, the appointment of Scott Millard as Chief Business Officer.
IONQ insider plans to sell common stock under Rule 144. A holder has filed a notice to sell 100,000 shares of IONQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $4,788,000 based on the pricing used in the notice. The filing states that 354,279,591 shares of IONQ common stock were outstanding at the time referenced. The securities were acquired as restricted stock units from the issuer on December 10, 2023, and fully vested on that date for this amount. Over the past three months, the same seller disposed of 19,976 common shares for gross proceeds of $886,966.36. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about IONQ’s operations.
IonQ, Inc. (IONQ) reported a new equity grant to one of its directors, who also serves as a special advisor. On 11/17/2025, the reporting person received 83,700 shares of common stock as a restricted stock unit (RSU) award at a stated price of $0 per share. Following this grant, the reporting person beneficially owns 86,763 shares of IonQ common stock in total.
The RSUs will vest over four years, with 1/16 of the award vesting quarterly on each March 10, June 10, September 10, and December 10, as long as the individual continues as a service provider through each vesting date. This filing is reported as a Form 4 for a single reporting person and reflects non-derivative stock ownership only, with no derivative securities reported.
IonQ (IONQ) reported an insider share purchase. A company director bought 2,000 shares of common stock on 11/11/2025 at a price of $54.815 per share. Following the transaction, the director beneficially owns 6,413 shares, held directly. The filing lists the transaction code as “P,” indicating an open‑market or private purchase.
IonQ, Inc. (IONQ) reported an insider equity grant. The company’s CFO & COO received 274,947 restricted stock units (RSUs) on 11/10/2025 at a stated price of $0. The RSUs vest in full on September 10, 2027, subject to continued service. Following this award, the officer beneficially owns 440,754 shares, reported as direct ownership.
IonQ, Inc. filed a prospectus supplement covering the resale of 2,108,993 shares of its common stock. The resale is by a selling stockholder under the company’s automatic shelf registration (Form S-3ASR, File No. 333-285279).
The filing was made pursuant to a Registration Rights Agreement with The University of Chicago, entered into on November 7, 2025 and effective as of November 10, 2025. IonQ also filed a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP as an exhibit.
This is an administrative step to register shares for potential resale by the holder; it does not, by itself, change IonQ’s operations or disclose new financial results.
IonQ, Inc. reported strong top-line growth but a large GAAP loss for the quarter ended September 30, 2025. Quarterly revenue reached $39.9 million, up from $12.4 million a year ago, while operating costs rose with scale, leading to a loss from operations of $168.8 million. A significant non-cash loss on change in fair value of warrant liabilities of $881.8 million drove the quarterly net loss to $1.06 billion.
Liquidity improved markedly: cash and cash equivalents were $346.0 million, with additional short-term investments of $736.3 million and long-term investments of $402.6 million. Financing inflows included $1.36 billion of proceeds from common stock and warrant issuance year-to-date. The balance sheet reflects recent acquisitions, with goodwill at $1.87 billion and intangible assets at $655.9 million. Shares issued and outstanding were 325.3 million as of September 30, 2025.
IonQ, Inc. furnished a press release announcing its financial results for the third quarter ended September 30, 2025. The press release is provided as Exhibit 99.1 and, along with the related disclosure, is designated as furnished under Item 2.02.
The company notes this information shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings except as specifically referenced. The 8-K also lists IonQ’s securities registered on the NYSE, including common stock under IONQ and warrants each exercisable for one share at $11.50 under IONQ WS.
IonQ, Inc. filed a prospectus supplement covering the resale by certain selling stockholders of an aggregate of 6,649,263 shares of its common stock, par value $0.0001 per share. The supplement is tied to the company’s automatic shelf registration statement on Form S-3ASR (File No. 333-285279).
The filing also includes a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP as Exhibit 5.1, with the related consent included as Exhibit 23.1. This action provides registered resale capacity for existing holders under the shelf framework.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
